PEYSAF WORTHALTER: Open Payments
NPI 1265627608 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,163 in 109 payments from 14 companies in 2025. Trend: 2023 $2,640 · 2024 $3,183 · 2025 $3,163
Food & beverage: $3,163
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 24 | $749 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 23 | $540 |
| E.R. Squibb & Sons, L.L.C. | 7 | $371 |
| Teva Pharmaceuticals USA, Inc. | 6 | $346 |
| Vanda Pharmaceuticals Inc. | 9 | $317 |
| Corium, LLC | 14 | $283 |
| ABBVIE INC. | 8 | $148 |
| Lundbeck LLC | 4 | $109 |
| Alkermes, Inc. | 3 | $77 |
| Janssen Pharmaceuticals, Inc | 3 | $55 |
Products named: REXULTI, CAPLYTA, COBENFY, UZEDY, Azstarys, FANAPT, VRAYLAR, HETLIOZ.
Industry payments across FL — which companies pay providers there.
